Effects of Sorafenib on C-Terminally Truncated Androgen Receptor Variants in Human Prostate Cancer Cells

Zengerling, Friedemann; Streicher, Wolfgang; Schrader, Andres J.; Schrader, Mark; Nitzsche, Bianca; Cronauer, Marcus V.; Höpfner, Michael

Erstveröffentlichung

2012

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Zengerling, Friedemann

Streicher, Wolfgang

Schrader, Andres J.

Schrader, Mark

Nitzsche, Bianca

et al.

Faculties

Fakultät für Naturwissenschaften

Institutions

UKU. Klinik für Urologie und Kinderurologie
Institut für Molekulare Endokrinologie der Tiere

Published in

International Journal of Molecular Sciences ; 13 (2012), 9. - S. 11530-11542. - eISSN 1422-0067

Link to publication

https://dx.doi.org/10.3390/ijms130911530

Keywords

sorafenib; truncated androgen receptor variants; castration resistant prostate cancer; PHASE-II; INHIBITION; GROWTH; MECHANISM; APOPTOSIS; MUTATION; PHOSPHORYLATION; STEROIDOGENESIS; PROLIFERATION; CHEMOTHERAPY

Dewey Decimal Group

DDC 540 / Chemistry & allied sciences
DDC 570 / Life sciences

Metadata

Show full item record